Replies to post #218801 on Amarin Corp Plc (AMRN)

[couldbebetter]

For all of those who say AMRN needs a confirmatory trial for the Reduce-It,
I wonder if AMRN could call EVAPORATE a confirmatory trial? If EVAPORATE
shows that Vascepa increases blood flow in arteries/blood vessels thus
giving us proof of an important mode of action. I also wonder if it
increases blood flow can it be inferred that blood flow also increases
in the brain? (I think the VA Vascepa study will be looking at that.)

One crazy idea would be to have AMRN sponsor seminars on Vascepa...
explaining how it works, what it is, how to get the best results
from its use. Do this in public forums like libraries for anyone
interested in Omega-3's for health benefits. (Maybe the FDA would
have issues with doing this.)